In human gastric cancer, down‐regulation of FOXA1 by the E3 ligase ZFP91 has been associated with promotion of chemoresistance [62], while in colon cancer down‐regulation of FOXA1 via NEDD4 promoted EMT and metastasis [63]. Here, FOXA1 is linked to gastric cancer.